November 26, 2014 7:35 PM ET

Life Sciences Tools and Services

Company Overview of Samsung Biologics Co., Ltd.

Company Overview

Samsung Biologics Co., Ltd. provides biologics development and manufacturing solutions for the full-scale manufacture of therapeutic proteins to the healthcare/biopharmaceutical industry. The company’s services include process development and optimization; cGMP production and manufacturing scale-up; quality assurance/quality control; stability programs; and regulatory compliance functions. It also engages in upstream development programs, downstream development programs, and process and analytical development programs; and manufacturing programs for cell line development, mammalian bulk manufacturing, clinical phase I/II/III manufacturing, full-scale commercial manufacturing, and aseptic fil...

125, Cheomdan-daero

Yeonsu-gu

Incheon,  406-840

South Korea

Founded in 2011

Phone:

82 0 455 3300

Fax:

82 0 455 3322

Key Executives for Samsung Biologics Co., Ltd.

Chief Executive Officer
Executive Vice President and Director
Executive Director
Vice President of Corporate Administration
Vice President
Compensation as of Fiscal Year 2014.

Samsung Biologics Co., Ltd. Key Developments

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.

Samsung Biologics Announces the Expansion of Existing Manufacturing Agreement with Bristol-Myers Squibb

Samsung BioLogics has announced that it has expanded its existing manufacturing agreement with Bristol-Myers Squibb. BMS's president of Global Manufacturing & Supply noted that the expanded agreement, will give the company flexibility to respond to increased demand in order to meet the global needs of patients. Details of which products will be covered by the deal or financial considerations have not yet been disclosed.

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. Financial terms of the agreement are not disclosed. Bristol-Myers Squibb and Samsung announced their first manufacturing agreement in July 2013 to collaborate in the production of a single commercial antibody cancer drug substance.

Similar Private Companies By Industry

Company Name Region
SPL Co., Ltd. Asia
Samsung Biologics Co., Ltd. Asia
Curachem Inc. Asia
ADM Korea Inc. Asia
SPL, Inc. Asia

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 11, 2014
Samsung Bioepis Co., Ltd.
Private Placement
December 20, 2013
--
Private Placement
December 20, 2013
Samsung Bioepis Co., Ltd.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Samsung Biologics Co., Ltd., please visit www.samsungbiologics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.